Hypercholesterolemia
📧 Sign up to get email alerts when something new happens for Hypercholesterolemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-11-01Clinical Trial Update: Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS) [Phase 3]
Phase 3 trial evaluating the safety and efficacy of the fixed-dose combination of simvastatin and extended-release niacin (Simcor) for hyper…
-
CLINICAL_TRIALS trial_result · 2006-10-31Clinical Trial Update: Rosuvastatin Affecting Aortic Valve Endothelium
This document reports a completed clinical trial studying the effect of rosuvastatin on the endothelium of the aortic valve. The study enrol…
-
FDA approval · 2006-10-24FDA Approved: COLESTIPOL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved an original application for Colestipol hydrochloride, a bile acid sequestrant used to treat hyperlipidemia and hypercholesterol…
-
FDA approval · 2006-10-23FDA Approved: PRAVASTATIN SODIUM — Original Application (Quallent)
FDA approves the original application (ANDA) for Pravastatin Sodium (generic pravastatin) from Quallent, establishing a generic statin produ…
-
FDA approval · 2006-10-23FDA Approved: PRAVASTATIN SODIUM — Original Application (Dr.Reddy's Laboratories Limited)
FDA approves Dr. Reddy's Laboratories Limited pravastatin sodium under an Original Application (ANDA). This marks a new generic product appr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-10-03FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) submitted by Organon LLC. This document confirms the app…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Comparing Effects of 3 Sources of Garlic on Cholesterol Levels [Phase 2, Phase 3]
A completed Phase 2/3 trial sponsored by NCCIH compared three garlic sources to assess their effects on cholesterol levels in individuals wi…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Safety and Effectiveness of Flaxseed for Reducing High Cholesterol [Phase 2, Phase 3]
A completed Phase 2/Phase 3 clinical trial evaluated the safety and effectiveness of flaxseed for reducing high cholesterol in individuals w…
-
CLINICAL_TRIALS trial_result · 2006-07-21Clinical Trial Update: Cholesterol-Lowering Effects of Policosanol [Phase 3]
A Phase 3 trial evaluating policosanol for lowering cholesterol was terminated; no efficacy or safety results are provided in this update.
-
CLINICAL_TRIALS trial_result · 2006-05-24Clinical Trial Update: The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia [NA]
This trial update reports on a completed study evaluating whether atorvastatin influences monocyte function in patients with coronary artery…
-
FDA approval · 2006-05-23FDA Approved: ZETIA — Supplemental Application (Organon LLC)
The FDA has approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC.
-
FDA approval ·FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
FDA approves Lipfendra (enlicitide), the first oral PCSK9 inhibitor, to reduce LDL cholesterol in adults with hypercholesterolemia as an adj…